Healthcare provider profile · identity verified

Norma Sanchez, MD

Family Practice · INGLEWOOD, CA · NPI 1528323482

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	564	221
Amlodipine Besylate	Amlodipine Besylate	344	130
Losartan Potassium	Losartan Potassium	248	84
Metformin Hcl	Metformin Hcl	226	81
Lisinopril	Lisinopril	218	71
Glipizide	Glipizide	201	66
Omeprazole	Omeprazole	175	87
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	155	53
Potassium Chloride	Potassium Chloride	152	57
Rosuvastatin Calcium	Rosuvastatin Calcium	139	53
Levothyroxine Sodium	Levothyroxine Sodium	134	42
Hydrochlorothiazide	Hydrochlorothiazide	119	41
Gabapentin	Gabapentin	112	44
Metformin Hcl Er	Metformin Hcl	107	40
Albuterol Sulfate Hfa	Albuterol Sulfate	104	55
Alendronate Sodium	Alendronate Sodium	89	30
Metoprolol Tartrate	Metoprolol Tartrate	82	29
Atenolol	Atenolol	80	28
Furosemide	Furosemide	73	30
Simvastatin	Simvastatin	73	26
Trazodone Hcl	Trazodone Hcl	67	25
Ozempic	Semaglutide	65	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	53	20
Spironolactone	Spironolactone	53	21
Terazosin Hcl	Terazosin Hcl	49	20
Carvedilol	Carvedilol	47	20
Ibuprofen	Ibuprofen	47	24
Humulin N Kwikpen	Insulin Nph Human Isophane	45	15
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	43	15
Triamcinolone Acetonide	Triamcinolone Acetonide	43	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	17
Tamsulosin Hcl	Tamsulosin Hcl	39	17
Duloxetine Hcl	Duloxetine Hcl	38	19
Jardiance	Empagliflozin	38	16
Meloxicam	Meloxicam	38	27
Acetaminophen-Codeine	Acetaminophen With Codeine	36	16
Allopurinol	Allopurinol	36	13
Hydralazine Hcl	Hydralazine Hcl	35	12
Hydrocortisone	Hydrocortisone	34	22
Humulin N	Insulin Nph Human Isophane	33	11
Tramadol Hcl	Tramadol Hcl	27	14
Clopidogrel	Clopidogrel Bisulfate	26	11
Pradaxa	Dabigatran Etexilate Mesylate	26	11
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Sertraline Hcl	Sertraline Hcl	25	13
Doxycycline Monohydrate	Doxycycline Monohydrate	24	24
Humulin R	Insulin Regular, Human	24	suppressed
Azelastine Hcl	Azelastine Hcl	23	20
Breyna	Budesonide/Formoterol Fumarate	22	12
Clobetasol Propionate	Clobetasol Propionate	22	13
Eliquis	Apixaban	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Prednisone	Prednisone	19	16
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Fluticasone Propionate	Fluticasone Propionate	18	12
Mupirocin	Mupirocin	18	17
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Acarbose	Acarbose	16	suppressed
Alvesco	Ciclesonide	16	suppressed
Famotidine	Famotidine	16	suppressed
Fluconazole	Fluconazole	16	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	11
Glipizide-Metformin	Glipizide/Metformin Hcl	15	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Naproxen	Naproxen	15	suppressed
Temazepam	Temazepam	15	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	14	14
Estradiol	Estradiol	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Victoza 2-Pak	Liraglutide	14	suppressed
Baclofen	Baclofen	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	13
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	12	12
Cyclosporine	Cyclosporine	12	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Finasteride	Finasteride	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error